[AsCNP_P22] ポスター22
Schizophrenia 1

[AsCNP-P22-1] Real-world effectiveness of antipsychotic monotherapy and polytherapy in 1543 patients with acute-phase schizophrenia

^○Kotaro HATTA¹, Hana HASEGAWA², Atsushi IMAI³, Yasuhiko SUDO⁴, Fumiyoshi MORIKAWA⁵, Shigemasa KATAYAMA⁶, Haruo WATANABE⁷, Takuya ISHIZUKA⁸, Mitsuru NAKAMURA⁹, Fuminari MISAWA¹⁰, Kiyoshi FUJITA¹¹, Shigeru OZAKI¹², Kentaro UMEDA³, Hiroyuki NAKAMURA¹³, Yutaka SAWA⁷, Naoya SUGIYAMA² (1. Department of Psychiatry, Juntendo University Nerima Hospital, Tokyo, Japan, 2. Department of Psychiatry, Numazu Chuo Hospital, Tokyo, Japan, 3. Department of Psychiatry, Tokyo Metropolitan Matsuzawa Hospital, Tokyo, Japan, 4. Department of Psychiatry, Tosa Hospital, Tokyo, Japan, 5. Department of Psychiatry, Asahikawa Keisenkai Hospital, Tokyo, Japan, 6. Department of Psychiatry, Seijin Hospital, Tokyo, Japan, 7. Department of Psychiatry, Sawa Hospital, Tokyo, Japan, 8. Department of Psychiatry, Hasegawa Hospital, Tokyo, Japan, 9. Department of Psychiatry, Narimasu Kosei Hospital, Tokyo, Japan, 10. Department of Psychiatry, Yamanashi Prefectural Kita Hospital, Tokyo, Japan, 11. Department of Psychiatry, The Okehazama Hospital, Tokyo, Japan, 12. Department of Psychiatry, Toshima Hospital, Tokyo, Japan, 13. Department of Environmental and Preventive Medicine, Kanazawa University Graduate School of Medical Science, Tokyo, Japan)